Publications
320 publications
Sort by: Date / Relevance
Asfotase alfa (Strensiq ®) for the treatment of hypophosphatasia (HPP)
Zorginstituut Nederland has completed its assessment whether asfotase alfa (Strensiq®) is interchangeable with a ...
Olaparib (Lynparza®) for the maintenance treatment of adult patients with carcinoma of the ovaries, tubes or peritoneum
Zorginstituut Nederland has completed its assessment whether olaparib (Lynparza®) as a monotherapy for the maintenance treatment ...
Trientine tetrahydrochloride (Cuprior®) the treatment of Wilson’s disease
Zorginstituut Nederland has completed its assessment whether trientine tetrahydrochloride (Cuprior®) is interchangeable with a ...
Hydroquinine (Inhibin®) for patients with nocturnal muscle cramps
Zorginstituut Nederland has assessed whether hydroquinine (Inhibin®) should be included in the medication reimbursement system ...
Voretigene neparvovec (Luxturna®) for the treatment of vision loss due to inherited retinal dystrophy with bi-allelic RPE65 mutations
Zorginstituut Nederland has completed its assessment whether voretigene neparvovec (Luxturna®) for the treatment of vision loss ...
Emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in patients with severe haemophilia A without inhibitors
Zorginstituut Nederland has completed its assessment whether emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in ...
GVS assessment of Bevespi® aerosphere for the treatment of COPD
Zorginstituut Nederland has completed its assessment whether Bevespi® aerosphere for the treatment of COPD, can be included in ...
GVS assessment of racecadotril (Hidrasec®) for the treatment of acute diarrhoea in infants (over 3 months of age) and children
The Zorginstituut has completed its assessment whether racecadotril (Hidrasec®) is interchangeable with another product that is ...
GVS assessment of a 4 component meningococcal B vaccine (Bexsero®)
Zorginstituut Nederland has completed its assessment whether the product 4 component meningococcal B vaccine (4CMenB) (Bexsero®) ...
GVS assessment of hydrocortisone (Alkindi®) for the treatment of adrenal insufficiency
Zorginstituut Nederland has completed its assessment whether hydrocortisone (Alkindi®) can be included in the Medication ...